當前位置：   首頁 > 需求大廳

 >  特色服務 

 >  信息服務 

1、Przemysl Chemiczny, 85(5), 349-350; 2006 2、Polymorphism of sodium valproate 【作 者】Mifsud, H.;Miguel, L.;Lavastre, V.;Maire, G. 【刊 名】Calorim. Anal. Therm. 【出版日期】1993 【卷 號】Vol.24 【頁 碼】309-312 3、Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC 4、[Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group] 5、Ital J Gastroenterol. 1995 Sep;27(7):376-7. TUDCA and UDCA are incorporated into hepatocyte membranes: different sites, but similar effects. Leuschner U1, Guldutuna S, Bhatti S, Elze A, Imhof M, You T, Zimmer G. Author information 6、AJHYA2 American Journal of Hygiene. (Baltimore, MD) V.1-80, 1921-64. For publisher information, see AJEPAS. Volume(issue)/page/year: 76,209,1962   [更多]

需求內容在圖片里面   [更多]

1、Arzneimittelforschung. 1985;35(7A):1203-8. Ohashi S, Iwatani M, Hyakuna Y, Morioka Y. Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion. 2、Arzneimittelforschung. 1985;35(7A):1149-54. K Kawamura, K Watanabe, Y Kimura. Effect of cilostazol, a new antithrombotic drug, on cerebral circulation 3、Gel formation of cefpodoxime proxetil 4、Gas chromatographic analysis of fosfomycin in plasma for pharmacokinetic analysis. GK Webster, RG Bell - Journal of AOAC International, 1999 - europepmc.org 5、Rydell N, Butler J, Balazs EA. Hyaluronic acid in synovial fluid.Ⅵ. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of the arthritis in track horses. Acta Vet Scand, 1970,11:139~146 6、Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol, 1974, 22:731~736 7、Weiss C, Balazs EA, St Onge R, et al. Clinical studies of the intra-articular injection of Healon in the treatment of osteoarthritis of human knee. Semin Arhtritis Rheum, 1980, 11(Suppl 1):143~144 8、Punzi L, Schiavon F, Ramonda R, et al. Intra-articular hyaluronic acid in the treatment of inflammatory and non-inflammatory knee diffusions. Curr Ther Res, 1988, 43:643~647 9、Nolan JP, reducing Catheter Related Bacteraemia in Haemodialysis. Vascular Access Soc. 5th Int. Congress of Vascular Access Soc, Nice, 2007 10、Arzneimittelforschung. 1984;34(9):948-52. Iron derivatives of modified milk protein.   [更多]

文獻： 1、" Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature. " Pharmacotherapy 2007;27:290–8. Page RL, Schwiesow J, Hilts A. 2、Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol 2013;39:310–24. Vehreschild JJ, Birtel A, Vehreschild MJGT, et al. 3、Tarantino MD, Fogarty P, Mayer B, Vasey SY, Brainsky A. Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia. Blood Coagul Fibrinolysis. 2013 Apr;24(3):284-96. doi: 10.1097/MBC.0b013e32835fac99. 4、J Med Chem, 51: 4632～4640. Org. Process Res. Dev. 2019, 23, 9, 2057-2068 Pharmazie 73(9):494-497 · September 2018 5、中國醫藥工業雜志 2012， 43（8）， 644-646 6、精細化工中間體2013，43（2），46-48 7、精細化工中間體2011，41（4），46-48 8、中國現代應用藥學2011，28（1），58-59 9、Chemical biology&Drug Design 2014, 83(3), 306-316 10、Letters in organic chemistry 2012, 9(4), 276-279 11、Medicines Evidence Commentary : Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders Source: National Institute for Health and Care Excellence - NICE - 21 January 2014 - Publisher: National Institute for Health and Care Excellence (NICE) 12、double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children 13、J. Med. Chem. 2018, 61, 5304?5322. 14、Chem. Biol. Drug Des. 2014, 83, 306?316. 15、J. Pharm. Biomed. Anal. 2009, 50, 144?150. 16、Int. J. Pharm. Sci. 2016, 8, 97?102. 17、J. Pharm. Biomed. Anal. 2010, 52, 493?507. 18、Org. Process Res. Dev. 2013, 17, 1036?1041. 19、Beilstein J. Org. Chem. 2011, 7, 442? 495. 20、Bioorg. Med. Chem. Lett. 2014, 24, 1108?1110. 21、New Activated PEG Derivatives for Affinity Partitioning 22、Population incidence and mortality of sepsis in an urban African setting 2013-2016 23、Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in   [更多]

急需冷敷凝膠、冷敷貼及傷口敷料的一類醫療器械全套備案申請資料   [更多]

求助西地那非原料藥信息   [更多]

提供藥廠及藥品轉讓項目/合作項目，需要具體的轉讓信，企業名稱，聯系方式，信息需真實可靠。   [更多]

1、Clinical Features and Molecular Genetics of HSD387 Deficiency and AKRlD1 Deficiency A case report of inborn errors of bile acid synthesis 2、3B-hydroxy-△5-C27 steroid dehydrogenase deficiency: a case report 3、Hallas G. Chem. and Ind. 1972,691 4、Chemical and biological characterization of iron-protein succinylate (ITF 282)' 5、Arzneimittelforschung. 1984;34(9):948-52. Iron derivatives of modified milk protein.   [更多]

EP10.0藥典： 1、Piperacillin Sodium EP10.0 2、替加環素Tigecycline EP10.0 3、阿托品atropine EP10.0 4、硫酸阿托品 EP10.0 5、2.6.31 EP10.0 6、EP10.0: Salmeterol Xinafoate 7、EP10.0: Preparations for inhalation 8、EP10.0: Pressurised pharmaceutical preparations" 9、EP10:ceftazidime 10、Formoterol Fumarate EP10.0 11、乳酸依沙吖啶Ethacridine lactate monohydrate EP10.0 12、Aspartame的EP10.0標準 13、EP10.0 3.1.9 14、perindopril tert-butylamine的EP10.1標準 15、CALCIUM LEVOFOLINATE HYDRATE EP10.0 16、Deslanoside EP10 17、Inhalation powders EP10 18、Fluconazole EP10 19、Nifedipine EP10 20、Calcium Dobesilate Monohydrate 羥苯磺酸鈣原料藥EP10.0的標準 21、EP10.0 Ipratropium bromide 22、Voriconazole EP10.0 23、Magnesium Stearate硬脂酸鎂 EP10.0 24、Colloidal Anhydrous Silica膠態無水二氧化硅 EP10.0 25、Purified water 純化水 EP10.0 26、Povidone (K-90) 聚維酮 (K-90) EP10.0 27、Hydroxypropyl cellulose (EF)羥丙纖維素 (EF) EP10.0 28、HPMC E-15羥丙甲纖維素E-15 EP10.0 29、Purified Talc 滑石粉 EP10.0 30、Pregelatinised Starch 預膠化淀粉 EP10.0 31、Lactose Monohydrate一水乳糖 EP10.0 32、lsopropyl Alcohol異丙醇 EP10.0 33、Titanium dioxide二氧化鈦 EP10.0 34、Polyethylene glycol 400 聚乙二醇400 EP10.0 35、氨丁三醇 TROMETAMOL EP10.0 36、依地酸鈣鈉 SODIUM CALCIUM EDETATE EP10.0 37、碘帕醇 IOPAMIDOL EP10.0 38、甘露醇 MANNITOL 查EP10.0 39、Macrogol 4000 EP10.0 40、鹽酸二甲雙胍Metformin hydrochloride，EP10.0 41、Polyoxyl castor oil EP10.0 42、Ascorbic Acid-EP10.0 43、EP10.0中的（5.1.8） 44、EP10.0中的（5.1.4） 45、Carboxymethylcellulose sodium的最新歐洲藥典，然后這個monograph（專著）里面有一個取代度的具體方法。 EP10.0 46、Tranexamic Acid EP10.0 47、歐洲藥典10.0版Starches hydrocyethyl 48、Dextrose和Glucose monohydrate EP10標準 49、Oxcarbazepine EP10標準 50、Human albumin solution EP10標準 51、Cefoperazone Sodium EP10.0 52、Sulbactam Sodium EP10.0 53、Azithromycin、 EP10標準 54、Aripiprazole EP10.0 55、 Candesartan cilexetil EP10.0 56、Clopidogrel besilate EP10.0 57、Clopidogrel hydrogen sulfate EP10.0 58、Clopidogrel hydrochloride EP10.0 59、Duloxetine hydrochloride EP10.0 60、Galantamine hydrobromide EP10.0 61、Irbesartan EP10.0   [更多]

1、targeting inhaled steroids 文獻 2、Minerva Dietol Gastroenterol. 1989 Jul-Sep;35(3):175-89. [A selective antimuscarinic agent: pirenzepine. Review of its pharmacologic and clinical properties]. [Article in Italian] Del Tacca M, Danesi R, Blandizzi C, Bernardini MC. 3、See 1 citation found by title matching your search: J Pharmacol. 1985;16 Suppl 2:145-69. [MI cholinergic receptors of gastric secretion: current status]. [Article in French]、 4、Carrigan PJ, Papp K, Schulz G, Venable T. Bioavailability of valproate from divalproex sodium tablets. Abbott Laboratories, North Chicago, IL (unpublished data). 5、MITOXANTRONE - MECHANISM OF ACTION, ANTITUMOR-ACTIVITY, PHARMACOKINETICS, EFFICACY IN THE TREATMENT OF SOLID TUMORS AND LYMPHOMAS, AND TOXICITY，文獻 6、American Journal of Kidney Diseases Volume 70, Issue 6, December 2017, Pages 737-751 KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)   [更多]